vs
Clearfield, Inc.（CLFD）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是Clearfield, Inc.的1.4倍（$47.7M vs $34.3M），Clearfield, Inc.净利率更高（-1.8% vs -4.8%，领先3.0%），Clearfield, Inc.同比增速更快（-3.2% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $-2.4M），过去两年Clearfield, Inc.的营收复合增速更高（-3.5% vs -20.2%）
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市，是一家专注于光纤产品研发生产的企业，其产品主要应用于光纤通信网络建设领域，为通信基础设施部署提供相关硬件支撑。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
CLFD vs IRWD — 直观对比
营收规模更大
IRWD
是对方的1.4倍
$34.3M
营收增速更快
CLFD
高出44.1%
-47.3%
净利率更高
CLFD
高出3.0%
-4.8%
自由现金流更多
IRWD
多$77.0M
$-2.4M
两年增速更快
CLFD
近两年复合增速
-20.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.3M | $47.7M |
| 净利润 | $-614.0K | $-2.3M |
| 毛利率 | 33.2% | — |
| 营业利润率 | -5.3% | 14.3% |
| 净利率 | -1.8% | -4.8% |
| 营收同比 | -3.2% | -47.3% |
| 净利润同比 | 67.8% | -200.9% |
| 每股收益（稀释后） | $-0.04 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLFDIRWD
| Q4 25 | $34.3M | $47.7M | ||
| Q3 25 | $23.4M | $122.1M | ||
| Q2 25 | $49.9M | $85.2M | ||
| Q1 25 | $47.2M | $41.1M | ||
| Q4 24 | $29.7M | $90.5M | ||
| Q3 24 | $5.6M | $91.6M | ||
| Q2 24 | $48.8M | $94.4M | ||
| Q1 24 | $36.9M | $74.9M |
净利润CLFDIRWD
| Q4 25 | $-614.0K | $-2.3M | ||
| Q3 25 | $-9.1M | $40.1M | ||
| Q2 25 | $1.6M | $23.6M | ||
| Q1 25 | $1.3M | $-37.4M | ||
| Q4 24 | $-1.9M | $2.3M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | $-447.0K | $-860.0K | ||
| Q1 24 | $-5.9M | $-4.2M |
毛利率CLFDIRWD
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
营业利润率CLFDIRWD
| Q4 25 | -5.3% | 14.3% | ||
| Q3 25 | 10.3% | 61.8% | ||
| Q2 25 | 3.0% | 53.2% | ||
| Q1 25 | 0.6% | -70.7% | ||
| Q4 24 | -6.9% | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | -4.7% | 26.5% | ||
| Q1 24 | -26.4% | 14.7% |
净利率CLFDIRWD
| Q4 25 | -1.8% | -4.8% | ||
| Q3 25 | -38.8% | 32.8% | ||
| Q2 25 | 3.2% | 27.7% | ||
| Q1 25 | 2.8% | -90.9% | ||
| Q4 24 | -6.4% | 2.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | -0.9% | -0.9% | ||
| Q1 24 | -16.0% | -5.6% |
每股收益（稀释后）CLFDIRWD
| Q4 25 | $-0.04 | $0.01 | ||
| Q3 25 | $-0.65 | $0.23 | ||
| Q2 25 | $0.11 | $0.14 | ||
| Q1 25 | $0.09 | $-0.23 | ||
| Q4 24 | $-0.13 | $0.03 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | $-0.04 | $-0.01 | ||
| Q1 24 | $-0.40 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $96.4M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $249.7M | $-261.8M |
| 总资产 | $268.1M | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLFDIRWD
| Q4 25 | $96.4M | $215.5M | ||
| Q3 25 | $106.0M | $140.4M | ||
| Q2 25 | $117.2M | $92.9M | ||
| Q1 25 | $112.0M | $108.5M | ||
| Q4 24 | $113.0M | $88.6M | ||
| Q3 24 | $129.0M | $88.2M | ||
| Q2 24 | $123.8M | $105.5M | ||
| Q1 24 | $142.9M | $121.5M |
总债务CLFDIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | $2.2M | $198.8M | ||
| Q2 24 | $2.1M | $198.6M | ||
| Q1 24 | — | $398.3M |
股东权益CLFDIRWD
| Q4 25 | $249.7M | $-261.8M | ||
| Q3 25 | $256.2M | $-264.2M | ||
| Q2 25 | $264.5M | $-308.2M | ||
| Q1 25 | $265.9M | $-334.1M | ||
| Q4 24 | $267.4M | $-301.3M | ||
| Q3 24 | $275.8M | $-311.3M | ||
| Q2 24 | $274.6M | $-321.7M | ||
| Q1 24 | $279.2M | $-330.5M |
总资产CLFDIRWD
| Q4 25 | $268.1M | $396.9M | ||
| Q3 25 | $306.2M | $396.1M | ||
| Q2 25 | $314.7M | $342.9M | ||
| Q1 25 | $310.9M | $327.2M | ||
| Q4 24 | $303.2M | $350.9M | ||
| Q3 24 | $315.3M | $389.5M | ||
| Q2 24 | $318.1M | $395.6M | ||
| Q1 24 | $315.4M | $438.8M |
负债/权益比CLFDIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $74.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 156.3% |
| 资本支出强度资本支出/营收 | 2.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $127.0M |
8季度趋势，按日历期对齐
经营现金流CLFDIRWD
| Q4 25 | $-1.4M | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | $7.9M | $-15.1M | ||
| Q1 25 | $3.0M | $20.0M | ||
| Q4 24 | $7.2M | $15.2M | ||
| Q3 24 | $22.2M | $9.9M | ||
| Q2 24 | $4.0M | $33.5M | ||
| Q1 24 | $-5.7M | $45.0M |
自由现金流CLFDIRWD
| Q4 25 | $-2.4M | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | $7.5M | $-15.1M | ||
| Q1 25 | $654.0K | $19.9M | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $18.2M | $9.9M | ||
| Q2 24 | $2.8M | $33.4M | ||
| Q1 24 | $-7.7M | $44.9M |
自由现金流率CLFDIRWD
| Q4 25 | -7.1% | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | 15.1% | -17.7% | ||
| Q1 25 | 1.4% | 48.4% | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 323.0% | 10.8% | ||
| Q2 24 | 5.8% | 35.4% | ||
| Q1 24 | -20.8% | 60.0% |
资本支出强度CLFDIRWD
| Q4 25 | 2.9% | 0.0% | ||
| Q3 25 | 2.0% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 5.1% | 0.1% | ||
| Q4 24 | 7.0% | 0.0% | ||
| Q3 24 | 71.4% | 0.0% | ||
| Q2 24 | 2.5% | 0.1% | ||
| Q1 24 | 5.3% | 0.1% |
现金转化率CLFDIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | 4.93× | -0.64× | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
